TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
VTRS

Viatris Inc

Healthcare · Drug Manufacturers - Specialty & Generic

18.10$ -0.8% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

Viatris Inc (VTRS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 3,757 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement VTRS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
3,942 3,837 3,663 3,797 3,751 3,528 3,254 3,582 3,760 3,704 3,517 3,757 14,737
2,251 2,241 2,159 2,351 2,292 2,313 2,093 2,249 2,375 2,569 2,360 2,300 9,604
1,691 1,597 1,504 1,445 1,459 1,215 1,161 1,333 1,385 1,135 1,157 1,457 5,133
211 203 200 204 198 207 222 219 250 275 249 248 1,022
1,054 1,606 1,018 1,358 1,003 1,047 948 929 887 1,031 929 1,135 3,981
1,240 2,051 1,300 1,685 1,233 1,395 4,043 1,100 1,133 1,400 1,237 1,450 5,220
452 -455 204 -240 226 -180 -2,882 233 252 -266 -80 6.3 -87
142 141 138 146 146 120 116 117 120 120 120 121 480
402 -855 205 -392 91 -527 -3,097 -217 -7.9 -343 -247 -64 -662
71 -89 91 -65 -4.3 -10 -55 -213 120 -2.9 -424 55 -252
332 -766 114 -326 95 -517 -3,042 -4.6 -128 -340 176 -119 -411
1,223 -70 1,034 540 906 340 -2,317 578 800 543 644 653 2,641

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?